TEPEZZA (teprotumumab-trbw)

Tepezza is an insulin-like growth factor-1 receptor inhibitor used for the treatment of Thyroid Eye Disease (TED) also known as Graves’ Orbitopathy.

Recommended Dosage: The recommended dose of Tepezza is an intravenous infusion of 10 mg per kg for the initial dose followed by an intravenous infusion of 20 mg per kg every 3 weeks for 7 additional infusions. Do not administer tepezza injection as an intravenous push or bolus. It should not be infused concomitantly with other agents.

• Teprotumumab may cause infusion reactions. In patients who experience an infusion reaction, consideration should be given to pre-medicating with an antipyretic, antihistamine, corticosteroid or administering all subsequent infusions at a reduced infusion rate. 
• The teprotumumab 500 mg treatment may cause an exacerbation of preexisting inflammatory bowel disease (IBD). Monitor patients with inflammatory bowel disease for flare of disease. In case IBD exacerbation is suspected, dosage can be discontinued.
• Increased blood glucose or Hyperglycemia may occur in patients treated with Teprotumumab. Monitor patients for elevated blood glucose and signs/symptoms of hyperglycemia during therapy with Teprotumumab.
• Patients with pre-existing diabetes should be under appropriate glycemic control prior to receiving treatment tepezza 500 mg injection.
• Mechanisms of action of inhibiting insulin-like growth factor-1 receptor (IGF-1R) suggest that tepezza may cause fetal harm if administered to a pregnant woman. Females should inform their health specialist about a known or suspected pregnancy.

What documents are required to import TEPEZZA to India?

TEPEZZA (teprotumumab-trbw) injection can be imported by patients or government hospitals on the name of the patients only. 

The following documentation required to import the product:

• Valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patients Identity Proof (issued by Gov of India)

How does order be confirmed?

The order will be confirmed only after the receipt of:

• Valid prescription of Doctor
• Import permit if applicable

Is TEPEZZA available in India?

TEPEZZA (teprotumumab-trbw injection) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is facilitator providing input

• On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
• Medicine Price.
• Finding Genuine and reliable source from Canada, Europe, USA and Australia
• Ensuring 100% transparency.

TEPEZZA can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.

IPN (Indian Pharma Network) can facilitate the supply of TEPEZZA (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)

Please contact +91-9310090915 | Toll-Free No: 1800-889-1064 or write us at info@indianpharmanetwork.in for tepezza price in India. 

We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network is able to source TEPEZZA (Cancer Treatment Medicines) from across the globe, and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Tepezza®?

Teprotumumab is Generic Name for the trade name drug Tepezza®.

What is the Manufacturer Name of Tepezza®?

Tepezza® is manufactured by Horizon Therapeutics. 

Is Tepezza® approved by the FDA?

Yes, Tepezza® is approved by the FDA. Date of approval: January 21, 2020.

What is Tepezza®?

Tepezza® (teprotumumab-trbw) reduces eye bulging and double vision. It also enhances the signs and symptoms of Thyroid Eye Disease, including eye pain, redness, and swelling. 

What is the dosage and form of Tepezza® supplied?

Tepezza® is supplied as Injection: 500 mg lyophilized powder in a single-dose vial for reconstitution for intravenous administration. 

How much does Teprotumumab cost in India?

The teprotumumab cost in India is very reasonable. In order to procure this medication for Thyroid eye disease authentically, you can call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

What are the most common side effects due to Tepezza®? 

Most common side effects due to Tepezza® include: dry skin, muscle spasm, diarrhea, nausea, alopecia, fatigue, hyperglycemia, dysgeusia, hearing impairment  and headache. 

What are the storage conditions of Tepezza®?

Refrigerate tepezza injection 500 mg vial at 2°C to 8°C (36°F to 46°F) in the original carton until time of use in order to protect from the light. Do not freeze.

What are the Highlights of prescribing information for Tepezza®?

Click Here to download full  Tepezza prescribing information.